scispace - formally typeset
S

Samuel T. Wall

Researcher at Simula Research Laboratory

Publications -  57
Citations -  1429

Samuel T. Wall is an academic researcher from Simula Research Laboratory. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 19, co-authored 50 publications receiving 1210 citations. Previous affiliations of Samuel T. Wall include United States Department of Veterans Affairs & Norwegian University of Life Sciences.

Papers
More filters
Journal ArticleDOI

Theoretical impact of the injection of material into the myocardium: a finite element model simulation.

Samuel T. Wall, +4 more
- 12 Dec 2006 - 
TL;DR: Simulations indicate that the addition of noncontractile material to a damaged left ventricular wall has important effects on cardiac mechanics, with potentially beneficial reduction of elevated myofiber stresses, as well as confounding changes to clinicalleft ventricular metrics.
Journal ArticleDOI

A Method for Automatically Optimizing Medical Devices for Treating Heart Failure: Designing Polymeric Injection Patterns

Jonathan F. Wenk, +8 more
- 01 Dec 2009 - 
TL;DR: A finite element (FE) simulation-based method was developed in this study that can automatically optimize the injection pattern of the polymeric "inclusions" according to a specific objective function, using commercially available software tools.
Journal ArticleDOI

Biomimetic matrices for myocardial stabilization and stem cell transplantation

Samuel T. Wall, +5 more
- 15 Dec 2010 - 
TL;DR: Tunable bioactive semi-interpenetrating polymer network hydrogels with matrix metalloproteinase (MMP) labile crosslinkers are developed to be used as an assistive microenvironment for transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) into the infarcted myocardium to treat postinfarct cardiac injuries.
Journal ArticleDOI

Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart

Lik Chuan Lee, +9 more
- 03 Oct 2013 - 
TL;DR: These results support the novel concept that Algisyl-LVR™+CABG treatment leads to decreased myofiber stress, restored LV geometry and improved function.
Patent

Controlling stem cell destiny with tunable matrices

Kevin E. Healy, +6 more
TL;DR: In this article, a class of interpenetrating polymeric networks (IPNs) and semi-interpenetrating polymeric network (sIPN) which include a covalently grafted growth factor or differentiation factor for a stem cell was proposed.